| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8309556 | Clinica Chimica Acta | 2018 | 5 Pages |
Abstract
Our findings indicate that ITPA activities are elevated with RBV therapy, and this elevation may be a risk of anemia in late therapeutic phase in patients that began with low ITPA activity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Yoichi Tanaka, Hiroaki Yokomori, Katsuya Otori,